ABG Analytics logo
Get updates

Biogen Inc (NASDAQ: BIIB)

DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 09/10/2021
Closing price: 299.81
Support price level: N/A
Resistance price level: $327.78
Relative strength index (14-day RSI) 16.0
Beta 0.11
  • BIIB is one of this month's worst performers with a return of -12.0%, underperforming 90 percent of stocks in the S&P-100.

  • Down 10.7 percent, BIIB is one of this week's biggest decliners.

  • The price of this low-beta stock is expected to increase by 0.11% for every 1% increase in the S&P-500.

  • BIIB is one of this week's most volatile stocks in the S&P-100 with an estimated annualized standard deviation of 69.9%.

  • Volatility is forecast to fall over the next month.

  • With RSI < 30, BIIB is oversold. Odds slightly favor a short-term price reversal.

  • Price broke below prior support level - a short-term bearish signal.

Low High Price as % of Range
$236.26 $414.71 42.3%
200 day 50 day 20 day 10 day
$293.95 $337.42 $336.06 $328.27
(Annualized standard deviation)
Historical
(5 year)
Last month Current estimate Next month forecast
44.6% 37.4% 69.9% 48.9%
There is an estimated 5% probability that the stock price of Biogen Inc will fall by more than:
  • 19.0% in the next week.

  • 27.7% in the next month.

  • 114.8% in the next year.